Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Optimal management of ALK-positive NSCLC progressing on crizotinibGiulio Metro, Marco Tazza, Roberta Matocci, et al.
Med (New York, N.Y.)|January 13, 2024
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapyAndrea De Giglio, Alessandro Di Federico, Eleonora Gariazzo, et al.
Anticancer Research|May 1, 2007
Brain radiotherapy during treatment with anticonvulsant therapy as a trigger for toxic epidermal necrolysisGiulio Metro, Simona Pino, Domenica Pellegrini, et al.
Cancers|July 27, 2022
Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic StrategiesAndreas Koulouris, Christos Tsagkaris, Anna Chiara Corriero, et al.
Drugs in Context|October 28, 2022
Non-small-cell lung cancer: how to manage <i>ALK-, ROS1</i>- and <i>NTRK</i>-rearranged diseaseDaniele Marinelli, Marco Siringo, Giulio Metro, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2021
Supportive Care: Low Cost, High ValueRazvan Andrei Popescu, Fausto Roila, Jann Arends, et al.
Expert Opinion on Emerging Drugs|February 1, 2012
Emerging drugs for small cell lung cancer--an updateGiulio Metro, Simona Duranti, Matthias Joachim Fischer, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2021
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reportsAlessandro Inno, Nicola Maurea, Giulio Metro, et al.
Pageof 17